ERBB2 and breast carcinoma: Even though these findings are based on an analysis of only two datasets (GSE17907 and GSE45255), some of the results, such as “Extracellular matrix organization36”, “Integrin signaling pathway37”, “PDGF receptor signaling network38” and “Vitamin D metabolism39”, seem to be significant elements in HER2-enriched breast cancer.